Friday 6 November 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.

Revenue: +32.0%
EPS: −296.6%
Free cash flow: −52.3%
Total debt: +599.5%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

55.89 0.23 −0.41%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 0.0×
Fwd P/E: 32.7×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BioMarin Pharmaceutical Inc. (BMRN) P/E ratio

Alert me on P/E ratio

BioMarin Pharmaceutical Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,305× (November 2021) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BMRN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BioMarin Pharmaceutical Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BMRN/metrics/pe-ratio">BioMarin Pharmaceutical Inc. (BMRN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	32.7×	11.78%
FY2024	29.2×	(73.48%)
FY2023	110×	(15.68%)
FY2022	131×	—
FY2021	0.0×	—
FY2020	18.6×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	151×	273.18%
Mar 2026	40.4×	23.57%
Dec 2025	32.7×	63.99%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 1,305×

Ten-year median 16.6×

Current reading's percentile 47

Company	P/E ratio
TWST Twist Bioscience Corporation compare	n/m
IBRX ImmunityBio, Inc. compare	n/m
KYMR Kymera Therapeutics, Inc. compare	n/m
BMRN BioMarin Pharmaceutical Inc.	n/m
SMMT Summit Therapeutics PLC compare	n/m
PCVX Vaxcyte, Inc. compare	n/m
TGTX TG Therapeutics, Inc. compare	19.1×
TECH Bio-Techne Corp compare	62.2×
CAI Caris Life Sciences,�Inc. compare	77.7×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

BioMarin Pharmaceutical Inc. (BMRN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BMRN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BMRN

Stockrow Weekly